Trial Profile
A Phase IIa, Randomized, Controlled, Double-Blind, Dose-Finding Study Evaluating the Safety and Pharmacodynamics of CNS 7056 in Patients Undergoing Diagnostic Upper GI Endoscopy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2019
Price :
$35
*
At a glance
- Drugs Remimazolam (Primary) ; Midazolam
- Indications Sedation
- Focus Therapeutic Use
- Sponsors PAION
- 05 Dec 2014 New trial record